Willnow et al., 2021 - Google Patents
Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor nicheWillnow et al., 2021
- Document ID
- 12494092650392676927
- Author
- Willnow D
- Benary U
- Margineanu A
- Vignola M
- Konrath F
- Pongrac I
- Karimaddini Z
- Vigilante A
- Wolf J
- Spagnoli F
- Publication year
- Publication venue
- Nature
External Links
Snippet
Studies based on single cells have revealed vast cellular heterogeneity in stem cell and progenitor compartments, suggesting continuous differentiation trajectories with intermixing of cells at various states of lineage commitment and notable degrees of plasticity during …
- 238000004458 analytical method 0 title description 25
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Willnow et al. | Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor niche | |
| Han et al. | The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis | |
| Byrnes et al. | Lineage dynamics of murine pancreatic development at single-cell resolution | |
| Boretto et al. | Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability | |
| Bastidas-Ponce et al. | Comprehensive single cell mRNA profiling reveals a detailed roadmap for pancreatic endocrinogenesis | |
| Jiang et al. | A differentiation roadmap of murine placentation at single-cell resolution | |
| Clavería et al. | Myc-driven endogenous cell competition in the early mammalian embryo | |
| Pomreinke et al. | Dynamics of BMP signaling and distribution during zebrafish dorsal-ventral patterning | |
| Nowotschin et al. | The emergent landscape of the mouse gut endoderm at single-cell resolution | |
| Tomic et al. | Phospho-regulation of ATOH1 is required for plasticity of secretory progenitors and tissue regeneration | |
| Hamada et al. | Involvement of Delta/Notch signaling in zebrafish adult pigment stripe patterning | |
| Kemler et al. | Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast | |
| Drummond et al. | Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors | |
| Förster et al. | Reelin, Disabled 1, and β1 integrins are required for the formation of the radial glial scaffold in the hippocampus | |
| Lindvall et al. | The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development | |
| Wang et al. | A time-and matrix-dependent TGFBR3–JUND–KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies | |
| Wilson et al. | Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors | |
| Melendez et al. | TGFβ signalling acts as a molecular brake of myoblast fusion | |
| Nigmatullina et al. | Id2 controls specification of Lgr5+ intestinal stem cell progenitors during gut development | |
| Trowe et al. | Canonical Wnt signaling regulates smooth muscle precursor development in the mouse ureter | |
| McDole et al. | Generation and live imaging of an endogenous Cdx2 reporter mouse line | |
| Destalminil-Letourneau et al. | The vascular niche controls Drosophila hematopoiesis via fibroblast growth factor signaling | |
| Harari et al. | Pancreatic pericytes originate from the embryonic pancreatic mesenchyme | |
| Lee et al. | Overexpression of Fgfr2c causes craniofacial bone hypoplasia and ameliorates craniosynostosis in the Crouzon mouse | |
| Bhattacharyya et al. | Macrophage Cx43 is necessary for fibroblast cytosolic calcium and lung fibrosis after injury |